Differential effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes

被引：0
|
作者：
Stocker, DJ [1 ]
Taylor, AJ [1 ]
Jezior, MR [1 ]
Langley, RW [1 ]
Vigersky, RA [1 ]
机构：
[1] Walter Reed Army Med Ctr, Washington, DC 20307 USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3825
引用
收藏
页码：U906 / U906
页数：1
相关论文
共 50 条
  • [1] A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes
    Stocker, Derek J.
    Taylor, Allen J.
    Langley, Roy W.
    Jezior, Mattliew R.
    Vigersky, Robert A.
    AMERICAN HEART JOURNAL, 2007, 153 (03) : 445.e1 - 445.e6
  • [2] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Evren Fidan
    H. Onder Ersoz
    Mustafa Yilmaz
    Hulya Yilmaz
    Mustafa Kocak
    Caner Karahan
    Cihangir Erem
    Acta Diabetologica, 2011, 48 : 297 - 302
  • [3] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [4] Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes
    Stage, Tore Bjerregaard
    Christensen, Mette-Marie Hougaard
    Jorgensen, Niklas Rye
    Beck-Nielsen, Henning
    Brosen, Kim
    Gram, Jeppe
    Frost, Morten
    BONE, 2018, 112 : 35 - 41
  • [5] Metabolic effects of rosiglitazone and metformin in Greek patients with recently diagnosed type 2 diabetes
    Iliadis, Fotios
    Kadoglou, Nikolaos P.
    Hatzitolios, Apostolos
    Karamouzis, Michalis
    Alevizos, Miltiadis
    Karamitsos, Dimitrios
    IN VIVO, 2007, 21 (06): : 1107 - 1114
  • [6] The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus
    Jung, HS
    Youn, BS
    Cho, YM
    Yu, KY
    Park, HJ
    Shin, CS
    Kim, SY
    Lee, HK
    Park, KS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (03): : 314 - 320
  • [7] Differential rosiglitazone effects on cardiovascular diseases in VA type 2 diabetes patients
    Wang, Chenpin
    Haffner, Steve
    Defronzo, Ralph
    Pugh, Jacqueline
    DIABETES, 2008, 57 : A179 - A179
  • [8] Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
    Zinman, Bernard
    Haffner, Steven M.
    Herman, William H.
    Holman, Rury R.
    Lachin, John M.
    Kravitz, Barbara G.
    Paul, Gitanjali
    Jones, Nigel P.
    Aftring, R. Paul
    Viberti, Giancarlo
    Kahn, Steven E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 134 - 142
  • [9] Metformin/rosiglitazone combination pill (Avandamet®) for the treatment of patients with Type 2 diabetes
    Smiley, Dawn
    Umpierrez, Guillermo
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1353 - 1364
  • [10] Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
    Kadoglou, Nikolaos P. E.
    Tsanikidis, Hercules
    Kapelouzou, Alkistis
    Vrabas, Ioannis
    Vitta, Ioulia
    Karayannacos, Panayotis E.
    Liapis, Christos D.
    Sailer, Nikolaos
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (03): : 373 - 379
12345